ICON plc is a global provider of outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, and government and public health organizations. With its headquarters in Dublin, Ireland, the company specializes in the strategic development, management, and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON plc has been recognized for its innovative clinical research, offering services that include clinical trials management, biometric activities, consulting, imaging, contract staffing, laboratories, and real-world & late phase research. Dedicated to delivering successful outcomes, ICON leverages its global infrastructure and expertise to assist clients in transforming scientific research into medical innovation.